Influenza vaccination and Guillain-Barré syndrome

The Lancet Infectious Diseases

Volumn 14, Issue 5, 2014, Pages 369-370

  Kwong, Jeffrey C ^a,b,c,g   Crowcroft, Natasha S ^c,d,g   Wilson, Kumanan ^a,e,f   McGeer, Allison J ^c,d   Deeks, Shelley L ^c,g  

^a INSTITUTE FOR CLINICAL EVALUATIVE SCIENCES   (Canada)

^b Department of Family and Community Medicine ^*  (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

^d UNIVERSITY OF TORONTO   (Canada)

^e OTTAWA HOSPITAL RESEARCH INSTITUTE   (Canada)

^f UNIVERSITY OF OTTAWA   (Canada)

^g PUBLIC HEALTH ONTARIO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

FEMALE; GUILLAIN-BARRE SYNDROME; HUMANS; INFLUENZA VACCINES; INFLUENZA, HUMAN; MALE; VACCINATION;

EID: 84899009946     PISSN: 14733099     EISSN: 14744457     Source Type: Journal    
DOI: 10.1016/S1473-3099(14)70716-9     Document Type: Letter

References (3)

1. Tomljenovic L, Shoenfeld Y Association between vaccination and Guillain-Barré syndrome. Lancet Infect Dis 2013, 13:730-731.
2. Kwong JC, Vasa PP, Campitelli MA, et al. Risk of Guillain-Barré syndrome after seasonal influenza vaccination and influenza health-care encounters: a self-controlled study. Lancet Infect Dis 2013, 13:769-776.
3. Poser CM, Behan PO Late onset of Guillain-Barré syndrome. J Neuroimmunol 1982, 3:27-41.